See also this year's filing and all EDGAR filings for this company.
PDF Report 0001035422_2013_CTT_Pharmaceutical_Holdings_INC.pdf
Logs
| error | Negative Expenses, ignoring company. | pre-agg | {'expenses': -92201} |
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('EntityCommonStockSharesOutstanding')"} |
Graph
Absolute values for 0001035422, CTT Pharmaceutical Holdings INC
| xvar | xval | |
|---|---|---|
| 0 | PropertyPlantAndEquipment | 0 |
| 1 | AssetsCurrent | 203,079 |
| 2 | AssetsNonCurrent | 0 |
| 3 | IntangibleAssets | 0 |
| 4 | remainder_Assets | 0 |
| 5 | LiabilitiesCurrent | 589,413 |
| 6 | LiabilitiesNonCurrent | 0 |
| 7 | remainder_Liabilities | 0 |
| 8 | GeneralAndAdministrativeExpense | 158,353 |
| 9 | CostOfRevenue | 0 |
| 10 | DepreciationDepletionAndAmortization | 0 |
| 11 | remainder_Expenses | 1,036,554 |
| 12 | remainder_Revenues | 53.0 |
| 13 | remainder_NetIncome | 191,666 |
| 14 | remainder_ComprehensiveNetIncome | 110,969 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 203,079 |
| 1 | Liabilities | 589,413 |
| 2 | Expenses | 1,194,907 |
| 3 | Revenues | 53.0 |
| 4 | StockholdersEquity | -386,334 |
| 5 | NetIncome | -1,003,188 |
| 6 | ComprehensiveNetIncome | -892,219 |
| 7 | BaseVar | 1,145,044 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -3.71 |
| 9 | EconomicCapitalRatio | 0.0974 |
Edgar->Model Mapping
Feature Distribution
